BioHealth News Archive
The Value of Bioscience Innovation in Growing Jobs and Improving Quality of Life | BIO
This ninth biennial TEConomy/BIO report focuses on the economic footprint of the industry geographically including the latest trends in the bioscience industry for the…
Read More
Congratulations to Our Digital RESI June Innovation Challenge Winners! | Next Phase Newsletter
Our 3-day Digital RESI June conference came to an end yesterday, and we are very excited to announce the Top 3 Winners of the…
Read More
AstraZeneca, Emergent BioSolutions sign $87M deal to produce U.S. supply of COVID-19 vaccine | FiercePharma
AstraZeneca made waves last week when it signed a massive $750 million deal to ramp production of a University of Oxford COVID-19 vaccine up…
Read More
Sirnaomics to spin off RNAimmune to develop novel mRNA therapeutics and vaccines – Maryland Daily Record
Sirnaomics Inc., a Gaithersburg-based biopharmaceutical company engaged in the discovery and development of RNAi therapeutics, Friday announced a corporate technology spinoff establishing an independent…
Read More
FDA Grant and Gift from Entrepreneur Provide $250K in Awards for Pediatric Medical Device Competition Focused on COVID-19 Innovations | Benzinga
WASHINGTON, June 11, 2020 /PRNewswire/ -- As medical data increasingly highlights the serious impact of COVID-19 on children's health, the National Capital Consortium for Pediatric Device…
Read More
BRIEF-Novo Nordisk To Acquire Corvidia Therapeutics – Reuters – congrats to Ram Aiyar former BHI EIR
* NOVO NORDISK TO ACQUIRE CORVIDIA THERAPEUTICS AND EXPAND PRESENCE IN CARDIOVASCULAR DISEASE * UNDER TERMS OF AGREEMENT, NOVO NORDISK WILL ACQUIRE ALL OUTSTANDING…
Read More
Viela Bio Announces U.S. FDA Approval of UPLIZNA™ (inebilizumab-cdon) for the Treatment of Neuromyelitis Optica Spectrum Disorder (NMOSD) Nasdaq:VIE
GAITHERSBURG, Md., June 11, 2020 (GLOBE NEWSWIRE) -- Viela Bio (Nasdaq:VIE) today announced that the U.S. Food and Drug Administration (FDA) has approved UPLIZNATM…
Read More
Emmes Announces Its Work on a Phase 3 Clinical Trial for Breakthrough Therapy Designation Product | BioSpace
ROCKVILLE, Md., June 15, 2020 /PRNewswire/ -- Emmes Group today announced that it provided the Phase 3 clinical trial support for a new investigational cell therapy…
Read More
Charlottesville company develops test to predict most severe cases of COVID-19
CHARLOTTESVILLE, Va. (WVIR) - The COVID-19 pandemic has presented many complex challenges to those in the medical field. One Charlottesville-based company stepped up to…
Read More
The Top Biotech Companies That are Hiring – June 2020 · BioBuzz
Despite the uncertainty created by the COVID-19 pandemic, companies across the BioHealth Capital Region (BHCR) continue to hunt for talented life science professionals to…
Read More
2020 Life Science Venture Capital Funding Roundup for Q1/Q2 in the BioHealth Capital Region · BioBuzz
This has certainly been a year unlike any other for BioHealth Capital Region (BHCR) life science companies of all sizes and kinds. Just a…
Read More
FSIF COVID BIOSCIENCE APPLIES FOR PATENT ON INNOVATIVE NEW COVID-19 TEST
<p>Cambridge, MD, June 15 — FSIF COVID BioScience, a biotechnology company focused on harnessing the power of the human immune system to diagnosis and…
Read More
Virginia Based AMPEL BioSolutions’ Technology Predicts Severity of Illness in COVID19 Patients and Identifies Treatments
Charlottesville, Virginia. June 9, 2020. AMPEL BioSolutions announces genomic analysis and findings that could improve treatment of COVID19 patients with approved drugs such as…
Read More
Anthony D. Saleh, Ph.D., CEO of miRecule, joins Rich Bendis on BioTalk
miRecule CEO Anthony D. Saleh, Ph.D. guests on BioTalk to discuss his company, his many roles in startup companies, and being an Entrepreneur in…
Read More
Sign Up Now – June EIR Feedback Session
Are you a start-up in Maryland, DC or Virginia seeking feedback on your biohealth business idea, pitch deck, or commercialization plan? Schedule your complimentary…
Read More